top
Search terms
Results 1 - 2 of 2 - ordered by :
Plasma tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1): an independent predictor of poor response to cardiac resynchronization therapy
Ejhf

Introduction Cardiac resynchronization therapy (CRT) is considered a class I indication in patients with stable heart failure, NYHA functional class III-IV, ejection fraction (EF) ≤35%, and wide ...

European Journal of Heart Failure, Tolosana, Jose María, Mont, Lluís, Sitges, Marta, Berruezo, Antonio, Delgado, Victoria, Vidal, Bàrbara, Tamborero, David, Morales, Manel, Batlle, Montserrat, ...

Date : 01/05/2010 Item size : 172090 bytes
Plasma tissue inhibitor of matrix metalloproteinase‐1 (TIMP‐1): an independent predictor of poor response to cardiac resynchronization therapy
Ejhf

Introduction Cardiac resynchronization therapy (CRT) is considered a class I indication in patients with stable heart failure, NYHA functional class III-IV, ejection fraction (EF) ≤35%, and wide ...

European Journal of Heart Failure, Tolosana, Jose María, Mont, Lluís, Sitges, Marta, Berruezo, Antonio, Delgado, Victoria, Vidal, Bàrbara, Tamborero, David, Morales, Manel, Batlle, Montserrat, ...

Date : 01/05/2010 Item size : 174157 bytes